Liver Rapid Reference Set Application: Gary Norman-INOVA (2012)

Abbreviated Name
Liver Rapid Ref Set App: Norman (2012)
Lead Investigator
Norman, Gary L.INOVA Diagnostics Inc.
Coordinating Investigator
Feng, Ziding Fred Hutchinson Cancer Center
Involved Investigators


No abstract availalbe.


The EDRN reference set will provide us with an opportunity to test the present version of the assay on a new, well-characterized cohort that has not been subjected to multiple freeze/thaw cycles.

Analytic Method

Since this assay will be submitted to the FDA for 510(k) clearance, we will want to test a training set prior to the blinded test set. Statistical analysis will be conducted at the DMCC.


We have developed a new and novel assay for the detection of Golgi protein 73 (GP73), also known as Golgi membrane protein 1 (Golm1) or Golgi phosphoprotein 2 (Golph2), in serum/plasma. The clinical question is to determine the clinical utility of gp73 antigen detection by the new assay for early hepatocullular carcinoma (HCC) diagnosis, for risk-assessment of patients at high risk for progression of their liver disease, and for prognosis.


  • No publications available at this time for this protocol.


Data Collections

  • No data collections available at this time for this protocol.
 Team Project
Start Date
Jul 12 2012
Estimated Finish Date
Sep 12 2012
Finish Date
Sep 30 2012
Protocol ID
Protocol Type
Reference Set
Field of Research
Collaborative Group
G.I. and Other Associated Cancers Research Group
Cancer Types
  • Liver cell carcinoma
Phased Status

Associated Forms